RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
Abstract Esophageal squamous cell carcinoma (ESCC) is a prevalent malignancy with a high mortality rate, for which esophagectomy remains the cornerstone of curative treatment
And remember, the benefits of collagenlike stronger joints, healthier skin, and improved gut healthwill quickly outweigh a little initial bloating
MDA-MB-231 (female, ATCC Cat# HTB-26), MCF-7 (female, ATCC Cat# HTB-22), HeLa (female, ATCC Cat# CCL-2), A549 (male, ATCC Cat# CCL-185)
Intrinsic factor is a glycoprotein produced by gastric parietal cells that is absolutely essential for vitamin B12 absorption in the small intestine